Literature DB >> 27761762

Sarcoid-like reaction in a patient with uveitis and underlying cancer.

Isabel Pascual-Camps1,2, Nieves Alonso-Orcajo3, Juan Pablo de la Fuente3, Taygan Yilmaz4, Miguel Cordero-Coma3,5.   

Abstract

PURPOSE: Sarcoidosis is a granulomatous disease of unknown etiology. Occasionally, triggering causes are identified, such as neoplasms, and they are termed sarcoid-like reactions, which may appear in any sarcoidotic target tissue. Choroidal metastases appear as part of widespread metastatic disease or as the first suggestion of neoplastic disease. They can also be a part of the differential diagnosis of a spectrum of inflammatory eye diseases. We present a case in which a lung carcinoma, pulmonary and eye sarcoid-like reactions, and choroidal metastasis take place in the same patient. CASE REPORT: A 60-year-old male with a past history of pulmonary sarcoidosis and associated anterior uveitis was diagnosed with a lung carcinoma with no regional lymph nodes extension, so that the resection surgery was performed without additional systemic treatment. At the same time, he complained of visual acuity loss and pain in his right eye. An intense ocular inflammatory reaction and a choroidal mass compatible with metastasis were identified. A vitrectomy with an accompanied histological exam of the lesion was deemed inconclusive. Ocular symptoms progressively worsened showing mass growth, and as a result, an enucleation was performed and the histological study subsequently revealed metastasis from his lung carcinoma.
CONCLUSION: Sarcoid-like reactions may be due to incipient malignancies. Any diagnosis of sarcoidosis requires ruling out other diseases that can produce secondary sarcoid-like reactions. In addition, any choroidal mass suggestive of metastasis requires exclusion of metastatic disease even in the absence of clinical signs indicating tumor extension.

Entities:  

Keywords:  Choroidal metastasis; Lung cancer; Sarcoid-like reaction; Sarcoidosis; Uveitis

Mesh:

Year:  2016        PMID: 27761762     DOI: 10.1007/s10792-016-0379-0

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  8 in total

1.  Double cancers of the lung and esophagus associated with a sarcoid-like reaction in their regional lymph nodes: report of a case.

Authors:  T Kin; Y Shimano; Y Shinomiya; H Nakano
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  Sarcoid-like reaction-computed tomography features in 12 patients.

Authors:  Randy K Lau; Julie E Takasugi; J David Godwin; Sudhakar N J Pipavath
Journal:  J Comput Assist Tomogr       Date:  2015 Mar-Apr       Impact factor: 1.826

3.  Paraneoplastic sarcoid-like reactions and the eye.

Authors:  Saranya C Balasubramaniam; Diva R Salomão; John B Davies; Robert C Ramsay; Thomas M Habermann; George K Chow; Stephen A Boorjian; Jose S Pulido
Journal:  Retina       Date:  2015-04       Impact factor: 4.256

4.  Incidence and aetiologies of pulmonary granulomatous inflammation: a decade of experience.

Authors:  Alia Nazarullah; Robert Nilson; Diego Jose Maselli; Jaishree Jagirdar
Journal:  Respirology       Date:  2014-10-29       Impact factor: 6.424

Review 5.  Sarcoidosis.

Authors:  Dominique Valeyre; Antje Prasse; Hilario Nunes; Yurdagul Uzunhan; Pierre-Yves Brillet; Joachim Müller-Quernheim
Journal:  Lancet       Date:  2013-10-01       Impact factor: 79.321

6.  Granulomatous inflammation of pulmonary squamous cell carcinoma: a rare phenomenon.

Authors:  Shogo Tajima; Kenji Koda
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 7.  Sarcoidosis and cancer risk: systematic review and meta-analysis of observational studies.

Authors:  Martina Bonifazi; Francesca Bravi; Stefano Gasparini; Carlo La Vecchia; Armando Gabrielli; Athol U Wells; Elisabetta A Renzoni
Journal:  Chest       Date:  2015-03       Impact factor: 9.410

Review 8.  Choroidal metastases: origin, features, and therapy.

Authors:  Sruthi Arepalli; Swathi Kaliki; Carol L Shields
Journal:  Indian J Ophthalmol       Date:  2015-02       Impact factor: 1.848

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.